Archives
How Condensate Coronas Transfer Biomolecules
2026-11-05
A Nature Materials study describes rare nanoparticle–condensate hybrids that acquire cell-derived proteins and RNAs, leave donor cells, and deliver cargo to recipient-cell compartments. The findings clarify a possible route for intracellular access while leaving important questions about frequency, cargo functionality, biological generality, and translational relevance.
When Research Context Changes a CRISPR Result
2026-11-05
A genome-editing result can mean very different things depending on the cellular model, perturbation scale, delivery context, comparator and readout. This editorial examines how those contexts shape interpretation of multiplexed CRISPR–Cas findings, separating molecular evidence from claims about cell function, safety or therapeutic value.
What Multiplex CRISPR Comparisons Really Establish
2026-11-04
Published evidence supports multiplex CRISPR–Cas as a versatile framework for coordinated genomic perturbation, but it does not resolve how editing efficiency, repair outcomes, specificity, delivery, and cellular toxicity trade off across models. The strongest conclusions concern feasibility and mechanism; therapeutic selectivity and broad material-specific performance remain less certain.
What Condensate Coronas Reveal About Cell-to-Cell Transfer
2026-11-04
A recent study describes rare hybrid particles in which synthetic nanoparticle cores acquire cell-derived biomolecular condensate coronas and are exported to other cells. The evidence supports a condensate-dependent route for transferring proteins and long RNAs, while leaving unresolved how often the process occurs, which molecular interactions control it, and how broadly it applies beyond the tested cellular models.
When Context Changes a Nanoparticle Result
2026-11-03
A reported nanoparticle-mediated transfer mechanism illustrates why material identity, cellular history, rare-event selection and readout choice determine what a result actually establishes.
How Multiplex CRISPR Produces Complex Genomic Outcomes
2026-11-03
Multiplex CRISPR changes genome editing from a single-locus perturbation into a problem of coordinated DNA repair, network interaction and cellular stress. The strongest evidence supports its ability to generate paired deletions and other structural variants, while the predictability of those outcomes and their translation beyond cultured cells remain more uncertain.
How Condensate Coronas Redirect Nanoparticle Trafficking
2026-11-02
A cell-biology study examines how a rare subset of synthetic nanoparticles acquires a cell-derived condensate corona, separates from the particle core inside endosomal compartments and redistributes biomolecular cargo to intracellular destinations. Comparisons with extracellular vesicles and a recognition perturbation support a mechanistic model in which condensate–cell interactions influence intracellular access, while the findings remain bounded by the cultured-cell models, heterogeneous particle populations and detection limits for RNA integrity.
Why Multiplex CRISPR Changes Genome Engineering
2026-11-02
A literature-focused analysis of how multiplex CRISPR–Cas editing extends genome engineering from single-site disruption to coordinated control of genes, regulatory elements and structural variation, while increasing concerns about DNA damage, specificity, delivery and translational access.
What Multiplex CRISPR Evidence Actually Shows
2026-11-01
Multiplex CRISPR–Cas can reveal gene interactions and generate complex genomic changes, but the same breadth increases uncertainty around repair outcomes, off-target effects, delivery, and cellular stress. A 2025 review places these capabilities in context and shows why a change in genotype or viability must be interpreted separately from evidence of mechanism, specificity, or therapeutic value.
What Multiplex CRISPR Evidence Shows
2026-10-31
A literature-focused analysis of how multiplexed CRISPR–Cas editing can reveal gene interactions, generate structural variants and alter cell states, while clarifying the limits imposed by off-target activity, delivery, model context and secondary evidence.
How Condensate Coronas Enable RNA Transfer
2026-10-30
A rare class of nanoparticle–cell hybrids acquires a cell-derived condensate corona containing intact proteins and RNA. The evidence supports a multistage mechanism involving selective corona formation, export, endosomal detachment and intracellular redistribution, while leaving the molecular recognition rules and general applicability unresolved.
Condensate Coronas and Cellular RNA Transfer
2026-10-30
A Nature Materials study describes rare nanoparticle–cell condensate hybrids that can acquire proteins and long RNAs, move between cells, and release cargo after endosomal entry. Its evidence supports a mechanistic model of condensate-mediated molecular transfer, while leaving major questions about event frequency, cargo co-packaging, receptor recognition and applicability beyond the tested cell systems.
What Multiplex CRISPR Evidence Actually Shows
2026-10-29
A literature-focused analysis of how multiplex CRISPR editing creates combined genetic perturbations, structural variants and regulatory changes, while distinguishing demonstrated mechanisms from translational uncertainty.
What Multiplex CRISPR Evidence Actually Shows
2026-10-29
A literature-focused analysis of how multiplex CRISPR–Cas editing creates combinatorial mutations, structural variants, and coordinated gene-regulatory changes, while distinguishing mechanistic promise from delivery, specificity, and translational limitations.
How Condensate Coronas Transfer RNA
2026-10-28
A recent study describes rare nanoparticle–condensate complexes that acquire cell-derived RNA-granule material, leave producer cells, and deliver intact proteins and RNAs to recipient-cell compartments. The findings distinguish these complexes from extracellular vesicles while leaving important questions about frequency, physiological relevance, and generalizability.